Size : | Price | Quantity | |
---|---|---|---|
50 mg | $30.00 | ||
250 mg | $100.00 |
Ibandronate (138926-19-9) is a clinically useful drug for the prevention and treatment of osteoporosis and skeletal fractures in patients with cancer. It is a potent inhibitor of farnesyl pyrophosphate synthase (IC50 = 20 nM) and strongly binds to hydroxyapatite.1
References/Citations:
1) Russell (2006), Ibandronate: Pharmacology and preclinical studies; Bone 38 S7
Materials provided by Focus Biomolecules are for laboratory research use only and are not intended for human or veterinary applications. Please note that we do not sell to individuals and that all orders placed by non-research organizations will incur a $20 restocking/refund fee
Ibandronate (138926-19-9) is a clinically useful drug for the prevention and treatment of osteoporosis and skeletal fractures in patients with cancer. It is a potent inhibitor of farnesyl pyrophosphate synthase (IC50 = 20 nM) and strongly binds to hydroxyapatite.1
References/Citations:
1) Russell (2006), Ibandronate: Pharmacology and preclinical studies; Bone 38 S7
Calculate the molar concentration, mass or volume in a solution.
Concentration × Volume × Molecular Weight = Mass
For Postdoc
Customers!
Website Created by Advanta Advertising LLC.